EFFECTS OF 3-O-METHYL DOPA ON L-DOPA-FACILITATED SYNTHESIS AND EFFLUX OF DOPAMINE FROM RAT STRIATAL SLICES

被引:10
作者
CHANG, WY [1 ]
WEBSTER, RA [1 ]
机构
[1] UCL, DEPT PHARMACOL, LONDON WC1E 6BT, ENGLAND
关键词
DOPAMINE EFFLUX; L-DOPA; 3-O-METHYL DOPA; RAT STRIATAL SLICES;
D O I
10.1111/j.1476-5381.1995.tb17219.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of L-dopa on the spontaneous and KCl-evoked efflux of dopamine from rat striatal slices, measured by high performance liquid chromatography (h.p.l.c.) with electrochemical detection (e.c.d.) was investigated in the absence and presence of 3-O-methyl dopa (OMD), an O-methylated metabolite of L-dopa. 2 The addition of exogenous L-dopa (10 mu M) significantly increased both the spontaneous efflux of dopamine and that evoked by KCI. 3 In the presence of 50 mu M OMD, the effects of L-dopa on the spontaneous and KCl-evoked efflux of dopamine were smaller but only the former was significantly different from that in the absence of OMD. However, the total efflux of dopamine during the overall superfusion time (70 min) including KCI depolarization was significantly lower than in the absence of OMD. 4 Analysis of tissue content after superfusion revealed that the levels of dopa and dopamine in slices superfused with L-dopa in the presence of OMD were significantly higher than those superfused with L-dopa alone. 5 The finding that OMD significantly reduced the efflux of dopamine whilst increasing its concentration in striatal slices after L-dopa superfusion could explain the reduced efficacy seen after long-term therapy with L-dopa and a peripheral dopa decarboxylase inhibitor in Parkinsonian patients when plasma and brain OMD are very high.
引用
收藏
页码:2637 / 2640
页数:4
相关论文
共 17 条
[1]  
BARTHOLINI G, 1972, J PHARMACOL EXP THER, V183, P65
[2]   A SIMPLE INVITRO TECHNIQUE TO MEASURE THE RELEASE OF ENDOGENOUS DOPAMINE AND DIHYDROXYPHENYLACETIC ACID FROM STRIATAL TISSUE USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
BECKER, JB ;
CASTANEDA, E ;
ROBINSON, TE ;
BEER, ME .
JOURNAL OF NEUROSCIENCE METHODS, 1984, 11 (01) :19-28
[3]  
CHANG WY, 1993, BRIT J PHARMACOL, V108, pP278
[4]   EFFECTS OF D-AMPHETAMINE ON DOPAMINERGIC NEUROTRANSMISSION - A COMPARISON BETWEEN THE SUBSTANTIA-NIGRA AND THE STRIATUM [J].
ELVERFORS, A ;
NISSBRANDT, H .
NEUROPHARMACOLOGY, 1992, 31 (07) :661-670
[5]   LEVODOPA PHARMACOKINETIC MECHANISMS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE [J].
FABBRINI, G ;
JUNCOS, J ;
MOURADIAN, MM ;
SERRATI, C ;
CHASE, TN .
ANNALS OF NEUROLOGY, 1987, 21 (04) :370-376
[6]  
GERVAS JJ, 1983, NEUROLOGY, V33, P278, DOI 10.1212/WNL.33.3.278
[7]   TRANSMITTER-LIKE RELEASE OF ENDOGENOUS 3,4-DIHYDROXYPHENYLALANINE FROM RAT STRIATAL SLICES [J].
GOSHIMA, Y ;
KUBO, T ;
MISU, Y .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (06) :1725-1730
[8]   PROBLEMS AND UNANSWERED QUESTIONS CONCERNING LEVODOPA TREATMENT IN PARKINSONS-DISEASE [J].
HARDIE, RJ .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 :77-82
[9]  
KURUMA I, 1971, CLIN PHARMACOL THER, V12, P678
[10]   EFFECT OF ENTACAPONE, A PERIPHERALLY ACTING CATECHOL-O-METHYLTRANSFERASE INHIBITOR, ON THE MOTOR RESPONSE TO ACUTE TREATMENT WITH LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE [J].
MERELLO, M ;
LEES, AJ ;
WEBSTER, R ;
BOVINGDON, M ;
GORDIN, A .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (02) :186-189